HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada.

Abstract
Initiating highly active antiretroviral therapy (HAART) with low CD4 counts or AIDS-defining illnesses (ADIs) increases risk of treatment failure and death. We examined factors associated with late initiation among 18- to 29-year-olds within the Canadian Observational Cohort (CANOC) collaboration, a multi-site study of HIV-positive persons who initiated HAART after 2000. Late initiation was defined as beginning HAART with a CD4 count <200 cells/mm(3) and/or having a baseline ADI. Multivariable logistic regression was used to identify independent correlates of late initiation. In total, 1026 individuals (422 from British Columbia, 400 from Ontario, and 204 from Quebec) met our age criteria. At HAART initiation, median age was 27 years (interquartile range, 24, 28 years). A total of 412 individuals (40%) identified as late initiators. Late initiation was associated with female gender, age >25 years at initiation, initiating treatment in earlier years, and having higher baseline viral load. The high number of young adults in our cohort starting HAART late indicates important target populations for specialized services, increased testing, and linkages to care.
AuthorsAlexis K Palmer, Angela Cescon, Keith Chan, Curtis Cooper, Janet M Raboud, Caroline L Miller, Ann N Burchell, Marina B Klein, Nima Machouf, Julio S G Montaner, Chris Tsoukas, Robert S Hogg, Mona R Loutfy, CANOC Collaboration
JournalJournal of the International Association of Providers of AIDS Care (J Int Assoc Provid AIDS Care) 2014 Jan-Feb Vol. 13 Issue 1 Pg. 56-62 ISSN: 2325-9574 [Print] United States
PMID24309754 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Retroviral Agents
Topics
  • Adolescent
  • Adult
  • Anti-Retroviral Agents
  • Antiretroviral Therapy, Highly Active
  • Canada (epidemiology)
  • Cohort Studies
  • Female
  • HIV Infections (drug therapy, epidemiology)
  • Humans
  • Male
  • Multivariate Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: